Results 161 to 170 of about 53,608 (248)

Recurrent UTIs in Children With CAKUT

open access: yesJournal of Paediatrics and Child Health, EarlyView.
ABSTRACT Congenital abnormalities of the kidney and urinary tract (CAKUT) encompass diverse diagnoses that commonly present as urinary tract dilatation and are the leading cause of kidney failure in children. Antenatal hydronephrosis occurs in ~1% of pregnancies; most resolve spontaneously, but conditions such as posterior urethral valves (PUV ...
Lucielle Standish   +6 more
wiley   +1 more source

Management of Monosymptomatic Nocturnal Enuresis in Children: A Pilot Randomised Control Trial of Body‐Worn Versus Bell‐and‐Pad Alarm Device

open access: yesJournal of Paediatrics and Child Health, EarlyView.
ABSTRACT Aim To compare bell‐and‐pad alarm therapy to body‐worn alarm therapy for the management of monosymptomatic enuresis in children 6–16 years of age in Victoria, Australia. Method A sample of 76 children with monosymptomatic enuresis were randomly allocated to a control group (bell‐and‐pad alarm, n = 38) or an experimental group (body‐worn alarm,
Blake Peck   +12 more
wiley   +1 more source

A Year in the Bones: Investigating Bone Resorption Across a Reproductive Year in Wild Female Assamese Macaques

open access: yesJournal of Animal Physiology and Animal Nutrition, EarlyView.
ABSTRACT Reproduction places considerable metabolic demands on females, particularly during pregnancy and lactation, when calcium homeostasis and bone metabolism are challenged. Urinary C‐terminal telopeptide of type I collagen (CTX‐I) offers a useful non‐invasive marker to assess bone resorption.
Verena Behringer   +6 more
wiley   +1 more source

N‐methyl‐D‐aspartate receptor antagonists for controlling pain in dogs

open access: yesJournal of Small Animal Practice, EarlyView.
This is a mini review published by the World Small Animal Veterinary Association's Pain Committee. This article provides an assessment of the scientific evidence of N‐methyl‐d‐aspartate receptor antagonists for controlling pain in dogs while identifying current knowledge gaps.
P. W. Kronen   +6 more
wiley   +1 more source

Targeting Orexin 2 Receptors in Idiopathic Hypersomnia and Narcolepsy: A Randomised Phase 1b Proof‐Of‐Concept Study of Alixorexton

open access: yesJournal of Sleep Research, EarlyView.
Orexin 2 receptor agonists have demonstrated that targeting the orexin system may address symptoms of central disorders of hypersomnolence. Results of this phase 1 study support the phase 2 clinical evaluation of oral alixorexton in patients with IH, NT2 and NT1.
Ronald R. Grunstein   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy